{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:01:46Z","timestamp":1789794106238,"version":"4.0.1"},"reference-count":52,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","award":["QU-APC-2026"],"award-info":[{"award-number":["QU-APC-2026"]}],"id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]},{"award":["QU-APC-2026"],"award-info":[{"award-number":["QU-APC-2026"]}],"id":[{"id":"https:\/\/ror.org\/01wsfe280","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Endocrine resistance due to activating mutations in the estrogen receptor alpha (ER\u03b1), especially Y537S, is still a big challenge in the treatment of hormone receptor-positive breast cancer, and there is a need to develop new small-molecule inhibitors that can overcome ligand-independent receptor activation. We used an integrated machine learning and molecular dynamics (MD)-based virtual screening (VS) approach to identify potential computationally prioritized hits of ER\u03b1 Y537S in this study. Methods: The dataset (~3353 compounds) was characterized using molecular fingerprints and graphically represented by PCA and t-SNE to show structurally different clusters linked to potency (pIC50). To guarantee robust downstream model training, the diagnosis of structural and influential outliers was completed through the application of rigorous data quality control methods, including the Williams plot, Mahalanobis distance, and Cook\u2019s distance diagnostics. This was followed by multiple benchmarks of machine learning classifiers (random forest, SVM, KNN, and CNN) for activity classification, yielding the highest AUC of 0.95 for the random forest classifier. Interpretable structure\u2013activity insights were gained by the identification of key substructures of the fingerprint by SHAP and feature importance analysis that influence the predicted potency. Three lead candidates (Hit-1, Hit-2, and Hit-3) were screened and tested with a 200 ns all-atom MD simulation in comparison with a reference control to evaluate the binding stability. Comprehensive trajectory analysis, such as PCA, FEL, RDF, salt bridges, and DCCM, was completed following the structure-based identification of the most stable ligands. Results: Three candidates were identified as Hit-1, Hit-2, and Hit-3. Hit-3 was found to be bound in the most stable binding pose and had the most similar conformational behavior to the control, whereas Hit-2 showed transient pose instability associated with increased anti-correlated domain-level motions and an alternate high-salt-bridge conformational state. As no computational metric can be an absolute measure of experimental affinity, Hit-1 has the most favorable calculated end-point binding-energy estimate, while Hit-3 showed conformational stability in MD simulations. Conclusions: The computationally prioritized candidates can be subjected to further experimental testing, as the conducted docking, MD simulations, and end-point free energy analyses cannot establish overall compound binding, cell-based activity, pharmacological mechanism, or therapeutic efficacy.<\/jats:p>","DOI":"10.3390\/ph19091471","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:50:27Z","timestamp":1789566627000},"page":"1471","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cracking ER\u03b1 Y537S Resistance: Explainable Machine Learning-Guided Discovery and Molecular Dynamics Validation of Stable Candidate Ligands"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-0440","authenticated-orcid":false,"given":"Abdulmohsen M.","family":"Alruwetei","sequence":"first","affiliation":[{"name":"Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51431, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Clusan, L., Ferri\u00e8re, F., Flouriot, G., and Pakdel, F. (2023). A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076834"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41523-022-00470-6","article-title":"ER\u03b1-LBD, an Isoform of Estrogen Receptor Alpha, Promotes Breast Cancer Proliferation and Endocrine Resistance","volume":"8","author":"Strillacci","year":"2022","journal-title":"npj Breast Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8689986","DOI":"10.1155\/ijbc\/8689986","article-title":"Modifiable and Nonmodifiable Risk Factors for Breast Cancer: A Comprehensive Scoping Review","volume":"2026","author":"Momenimovahed","year":"2026","journal-title":"Int. J. Breast Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21614\/chirurgia.3100","article-title":"Breast Cancer: A Heterogeneous Pathology. Prognostic and Predictive Factors\u2014A Narrative Review","volume":"120","author":"Popa","year":"2025","journal-title":"Chirurgia"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mir, M.A., and Qayoom, H. (2023). Introduction to Breast Cancer. Therapeutic Potential of Cell Cycle Kinases in Breast Cancer, Springer.","DOI":"10.1007\/978-981-19-8911-7"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100284","DOI":"10.1016\/j.modpat.2023.100284","article-title":"The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer","volume":"36","author":"Makhlouf","year":"2023","journal-title":"Mod. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Saha, T., and Lukong, K.E.E. (2025). Decoding Estrogen Receptor and GPER Biology: Structural Insights and Therapeutic Advances in ER\u03b1\u2212 Positive Breast Cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1513225"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Miziak, P., Baran, M., B\u0142aszczak, E., Przybyszewska-Podstawka, A., Ka\u0142afut, J., Smok-Kalwat, J., Dmoszy\u0144ska-Graniczka, M., Kie\u0142bus, M., and Stepulak, A. (2023). Estrogen Receptor Signaling in Breast Cancer. Cancers, 15.","DOI":"10.3390\/cancers15194689"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1038\/s41598-025-90456-8","article-title":"A Reappraisal of Cell Cycle Phase Enrichment in Synchronized Estrogen Receptor-Positive Cell Models Derived from Breast Adenocarcinomas","volume":"15","author":"Toker","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/14737159.2019.1631799","article-title":"ESR1 Mutations: A New Biomarker in Breast Cancer","volume":"19","author":"Carausu","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"126398","DOI":"10.1016\/j.eswa.2025.126398","article-title":"T-SNE-PSO: Optimizing t-SNE Using Particle Swarm Optimization","volume":"269","author":"Allaoui","year":"2025","journal-title":"Expert Syst. Appl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00204-022-03252-y","article-title":"Prediction Reliability of QSAR Models: An Overview of Various Validation Tools","volume":"96","author":"De","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.drudis.2021.07.026","article-title":"Advances in the Computational Landscape for Repurposed Drugs against COVID-19","volume":"26","author":"Aronskyy","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.jcim.6c01425","article-title":"Chemically Interpretable Explanations for Molecular Property Prediction via Fragment-Level Shapley Values","volume":"66","author":"Roth","year":"2026","journal-title":"J. Chem. Inf. Model."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11716","DOI":"10.1021\/acs.jcim.5c02015","article-title":"Improving Machine Learning Classification Predictions through SHAP and Features Analysis Interpretation","volume":"65","author":"Bernal","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pappalardo, M., Sipala, F.M., Nicolosi, M.C., Guccione, S., and Ronsisvalle, S. (2024). Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies. Molecules, 29.","DOI":"10.3390\/molecules29225349"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1142\/S2737416525501133","article-title":"From Quantum Chemistry to Dynamics: Exploring Potential Inhibitors for Alongshan Virus RdRp Through Advanced Computational Techniques","volume":"25","author":"Khan","year":"2025","journal-title":"J. Comput. Biophys. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/mol.117.111385","article-title":"Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer","volume":"94","author":"Maximov","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_19","first-page":"2509","article-title":"Targeting Glycine N-Methyltransferase: A Computational Pipeline for Novel Anti-Pancreatic Cancer Leads","volume":"25","author":"Amin","year":"2025","journal-title":"J. Comput. Biophys. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.drudis.2017.01.005","article-title":"The Application of Principal Component Analysis to Drug Discovery and Biomedical Data","volume":"22","author":"Giuliani","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Graeff, G.R., Tonietto Mangini, A., and Dorn, M. (2026). Exploring Data Visualization Techniques in Molecular Dynamics: Analysis of Dynamic Cross-Correlation Maps as Dynamic Networks. Inf. Vis., 14738716261459476.","DOI":"10.1177\/14738716261459476"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145312","DOI":"10.1016\/j.molstruc.2026.145312","article-title":"Radial Distribution Function Assisted Small Angle X-Ray Scattering Analyses towards Decoding Nano-Macromolecular Structure of Coking Coal","volume":"1358","author":"Sharma","year":"2026","journal-title":"J. Mol. Struct."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1039\/D5NH00112A","article-title":"Salt-Bridge Mediated Cooperativity and Mechanical Stabilization of Tandem Spectrin Repeats","volume":"10","author":"Wang","year":"2025","journal-title":"Nanoscale Horiz."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Miandad, K., Ullah, A., Bashir, K., Khan, S., Abideen, S.A., Shaker, B., Alharbi, M., Alshammari, A., Ali, M., and Haleem, A. (2022). Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme. Molecules, 27.","DOI":"10.3390\/molecules27228103"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Palaniappan, M. (2024). Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer. Biomedicines, 12.","DOI":"10.20944\/preprints202411.0222.v1"},{"key":"ref_26","unstructured":"Su, J., Xin, C., Shang, A., Wu, S., Xie, Z., Xiong, R., Xu, X., Zhang, C., Chen, G., and Chan, Y.-T. (2025). Artificial Intelligence in Drug Discovery: A Comprehensive Review with a Case Study on Hyperuricemia, Gout Arthritis, and Hyperuricemic Nephropathy. arXiv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11779322241288704","DOI":"10.1177\/11779322241288703","article-title":"Investigating Lasofoxifene Efficacy against the Y537S+ F404V Double-Mutant Estrogen Receptor Alpha Using Molecular Dynamics Simulations","volume":"18","author":"Bouricha","year":"2024","journal-title":"Bioinform. Biol. Insights"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"16771","DOI":"10.1038\/s41598-020-73681-1","article-title":"Comparative Study between Deep Learning and QSAR Classifications for TNBC Inhibitors and Novel GPCR Agonist Discovery","volume":"10","author":"Tsou","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/2159-8290.CD-22-1387","article-title":"ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer","volume":"14","author":"Kingston","year":"2024","journal-title":"Cancer Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational Approaches Streamlining Drug Discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1038\/s41596-023-00885-w","article-title":"A Practical Guide to Machine-Learning Scoring for Structure-Based Virtual Screening","volume":"18","author":"Junaid","year":"2023","journal-title":"Nat. Protoc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"de Azevedo, D.Q., Castilho, R.O., G\u00f3mez-Garc\u00eda, A., and Medina-Franco, J.L. (2025). Molecular Databases. Computer-Aided and Machine Learning-Driven Drug Design: From Theory to Applications, Springer.","DOI":"10.1007\/978-3-031-76718-0_2"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11030-025-11287-3","article-title":"Unveiling Molecular Signatures for Precision Drug Design: Machine Learning Insights from Trypanothione Reductase, PKC-\u03b8, and CB1","volume":"30","author":"Sahu","year":"2026","journal-title":"Mol. Divers."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.14057","article-title":"Machine Learning Approaches and Their Applications in Drug Discovery and Design","volume":"100","author":"Priya","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Roy, S., Chatterjee, S., Bhattacharjee, A., Chattopadhyay, P., Saha, B., Dutta, S., and Basu, S. (2021). Overexpression of Efflux Pumps, Mutations in the Pumps\u2019 Regulators, Chromosomal Mutations, and AAC (6\u2032)-Ib-Cr Are Associated with Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.602724"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.1038\/s41598-023-41325-9","article-title":"Structure Based Virtual Screening and Molecular Simulation Study of FDA-Approved Drugs to Inhibit Human HDAC6 and VISTA as Dual Cancer Immunotherapy","volume":"13","author":"Shahab","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Valencia, E., Galvis, M., Nisperuza, J., Ballesteros, V., and Mesa, F. (2024). In Silico Evaluation of Potential NDM-1 Inhibitors: An Integrated Docking and Molecular Dynamics Approach. Pharmaceuticals, 17.","DOI":"10.3390\/ph17121715"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s42250-020-00162-3","article-title":"In-Silico Molecular Docking and ADME\/Pharmacokinetic Prediction Studies of Some Novel Carboxamide Derivatives as Anti-Tubercular Agents","volume":"3","author":"Abdullahi","year":"2020","journal-title":"Chem. Afr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1080\/07391102.2019.1700167","article-title":"Screening of Promising Molecules against MurG as Drug Target in Multi-Drug-Resistant-Acinetobacter baumannii-Insights from Comparative Protein Modeling, Molecular Docking and Molecular Dynamics Simulation","volume":"38","author":"Amera","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.matpr.2020.10.055","article-title":"Molecular Docking and ADMET Study of Bioactive Compounds of Glycyrrhiza glabra against Main Protease of SARS-CoV2","volume":"49","author":"Srivastava","year":"2022","journal-title":"Mater. Today Proc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4103\/mgmj.mgmj_245_23","article-title":"Bioavailability Predictions, Pharmacokinetics and Drug-Likeness of Bioactive Compounds from Andrographis Paniculata Using Swiss ADME","volume":"10","author":"Khare","year":"2023","journal-title":"MGM J. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sucharitha, P., Reddy, K.R., Satyanarayana, S.V., and Garg, T. (2022). Absorption, Distribution, Metabolism, Excretion, and Toxicity Assessment of Drugs Using Computational Tools. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection, Elsevier.","DOI":"10.1016\/B978-0-323-91172-6.00012-1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.55522\/jmpas.V12I5.4784","article-title":"Identification of Potential CDK 8 Inhibitor from Pyrimidine Derivatives via In-Silico Approach","volume":"12","author":"Patil","year":"2023","journal-title":"J. Med. Pharm. Allied Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Akash, S., Bay\u0131l, I., Rahman, M.A., Mukerjee, N., Maitra, S., Islam, M.R., Rajkhowa, S., Ghosh, A., Al-Hussain, S.A., and Zaki, M.E.A. (2023). Target Specific Inhibition of West Nile Virus Envelope Glycoprotein and Methyltransferase Using Phytocompounds: An in Silico Strategy Leveraging Molecular Docking and Dynamics Simulation. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1189786"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ghorayshian, A., Danesh, M., Mostashari-Rad, T., and Fassihi, A. (2023). Discovery of Novel RAR\u03b1 Agonists Using Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Studies. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0289046"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1039\/D5NJ01078K","article-title":"Hydrophobicity-Directed Structural Alteration in Cytochrome C Induced by Bile Salts: Physicochemical, Spectroscopic, and Atomic Force Microscopic Studies with Molecular Docking Analysis","volume":"49","author":"Sardar","year":"2025","journal-title":"New J. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/acs.jcim.3c00310","article-title":"Molecular Dynamics Simulation-Driven Focused Virtual Screening and Experimental Validation of Inhibitors for MTDH-SND1 Protein\u2013Protein Interaction","volume":"63","author":"Xu","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"ref_48","unstructured":"Rafique, A. (2023). Prediction of R-134a and DNAN Physical and Transport Properties from Computer Simulations, Wayne State University."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/cmdc.202000805","article-title":"Do Drug-Likeness Rules Apply to Oral Prodrugs?","volume":"16","author":"Protti","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10930-020-09953-6","article-title":"Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus Aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM\/MM","volume":"40","author":"Dalal","year":"2021","journal-title":"Protein J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1080\/07391102.2021.1989040","article-title":"Exploring the Interaction Mechanism between Potential Inhibitor and Multi-Target Mur Enzymes of Mycobacterium tuberculosis Using Molecular Docking, Molecular Dynamics Simulation, Principal Component Analysis, Free Energy Landscape, Dynamic Cross-Correlati","volume":"40","author":"Kumari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jmgm.2017.07.024","article-title":"Binding Mode Analysis, Dynamic Simulation and Binding Free Energy Calculations of the MurF Ligase from Acinetobacter baumannii","volume":"77","author":"Ahmad","year":"2017","journal-title":"J. Mol. Graph. Model."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1471\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:13:14Z","timestamp":1789791194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091471"],"URL":"https:\/\/doi.org\/10.3390\/ph19091471","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}